Literature DB >> 18365236

Subcellular expression pattern and role of IL-15 in pneumococci induced lung epithelial apoptosis.

Andreas C Hocke1, Ines K Hartmann, Julia Eitel, Bastian Optiz, Stefanie Scharf, Norbert Suttorp, Stefan Hippenstiel.   

Abstract

Streptococcus pneumoniae is the leading causative agent of community-acquired pneumonia. Induction of apoptosis in pulmonary epithelial cells by bacteria during pneumonia might be harmful to the host. Interleukin-15 (IL-15) has been demonstrated as an effective inhibitor of apoptosis and is expressed in lung epithelium on the mRNA and protein level. Therefore, we characterized the sub-cellular expression pattern of the short and long IL-15 isoforms in lung epithelial cells in vitro as well as its role in pneumococci-related lung epithelial cell apoptosis. We found an expression pattern for both IL-15 signal peptides in the pulmonary epithelial cell lines A549 and Beas-2B. Moreover, a strong co-localization of IL-15 and IL-15Ralpha was detected on cell surfaces. Compared to pro-inflammatory cytokine stimulation, neither IL-15 nor its trimeric receptor complex was up-regulated after pneumococcal infection. However, overexpression of IL-15 isoforms revealed IL-15LSP and IL-15Vkl as inhibitors of pneumococci induced apoptosis in pulmonary epithelial cells. Thus, IL-15 may act as an anti-apoptotic molecule in pneumococci infection, thereby suggesting IL-15 as a benefical cytokine in pulmonary host defense against infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365236     DOI: 10.1007/s00418-008-0414-y

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  61 in total

1.  Dendritic cell-derived IL-15 controls the induction of CD8 T cell immune responses.

Authors:  René Rückert; Katja Brandt; Elena Bulanova; Farhad Mirghomizadeh; Ralf Paus; Silvia Bulfone-Paus
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

2.  In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.

Authors:  G Zissel; I Bäumer; M Schlaak; J Müller-Quernheim
Journal:  Eur Cytokine Netw       Date:  2000-03       Impact factor: 2.737

Review 3.  IL-15/IL-15 receptor biology: a guided tour through an expanding universe.

Authors:  Vadim Budagian; Elena Bulanova; Ralf Paus; Silvia Bulfone-Paus
Journal:  Cytokine Growth Factor Rev       Date:  2006-06-30       Impact factor: 7.638

4.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Marker discrimination in transformation and mutation of pneumococcus.

Authors:  J G Tiraby; M S Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

6.  Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice.

Authors:  K Hirose; H Nishimura; T Matsuguchi; Y Yoshikai
Journal:  J Leukoc Biol       Date:  1999-09       Impact factor: 4.962

7.  Synthesis and secretion of interleukin-15 by freshly isolated human bronchial epithelial cells.

Authors:  Ning Ge; Yasuhiko Nishioka; Yoichi Nakamura; Yoshio Okano; Kazuo Yoneda; Hirohisa Ogawa; Akemi Sugita; Hiroaki Yanagawa; Saburo Sone
Journal:  Int Arch Allergy Immunol       Date:  2004-10-04       Impact factor: 2.749

8.  Correlation between interleukin-15 and granzyme B expression and acute lung allograft rejection.

Authors:  Ruili Shi; Junbao Yang; Andrés Jaramillo; Nancy S Steward; Aviva Aloush; Elbert P Trulock; G Alexander Patterson; Manikkam Suthanthiran; T Mohanakumar
Journal:  Transpl Immunol       Date:  2004-01       Impact factor: 1.708

9.  Cell-specific interleukin-15 and interleukin-15 receptor subunit expression and regulation in pneumococcal pneumonia--comparison to chlamydial lung infection.

Authors:  Andreas C Hocke; Matthias P Lampe; Martin Witzenrath; Hans Mollenkopf; Jens Zerrahn; Bernd Schmeck; Ulrich Kessler; Matthias Krüll; Sven Hammerschmidt; Stefan Hippenstiel; Hartwig Schütte; Norbert Suttorp; Simone Rosseau
Journal:  Cytokine       Date:  2007-07-03       Impact factor: 3.861

10.  HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL.

Authors:  Constantinos Petrovas; Yvonne M Mueller; Ioannis D Dimitriou; Paul M Bojczuk; Karam C Mounzer; James Witek; John D Altman; Peter D Katsikis
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  5 in total

1.  A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection.

Authors:  Katherine C Verbist; Charles J Cole; Mary B Field; Kimberly D Klonowski
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

Review 2.  State-of-the-art technologies, current opinions and developments, and novel findings: news from the field of histochemistry and cell biology.

Authors:  Esther Asan; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2008-11-05       Impact factor: 4.304

3.  TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.

Authors:  Patricia K A Mongini; Rashmi Gupta; Erin Boyle; Jennifer Nieto; Hyunjoo Lee; Joanna Stein; Jela Bandovic; Tatjana Stankovic; Jacqueline Barrientos; Jonathan E Kolitz; Steven L Allen; Kanti Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

4.  Contribution of Puma to Inflammatory Resolution During Early Pneumococcal Pneumonia.

Authors:  Daniel E Kennedy Ii; Perceus Mody; Jean-Francois Gout; Wei Tan; Keun Seok Seo; Alicia K Olivier; Jason W Rosch; Justin A Thornton
Journal:  Front Cell Infect Microbiol       Date:  2022-05-26       Impact factor: 6.073

5.  IL-15 participates in the respiratory innate immune response to influenza virus infection.

Authors:  Katherine C Verbist; David L Rose; Charles J Cole; Mary B Field; Kimberly D Klonowski
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.